Showing results (201-210 of 242) with videos related to
Sort By:
Pageof 25
BJU International|December 20, 2014
Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancerAngelika Borkowetz, Ivan Platzek, Marieta Toma, et al.International Journal of Oncology|August 9, 2002
Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocolAxel Meye, Udo Bilkenroth, Uta Schmidt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011Benjamin Hager, Klaus Kraywinkel, Bastian Keck, et al.BMC Cancer|November 25, 2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatmentDoreen Huebner, Christiane Rieger, Ralf Bergmann, et al.Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.Biomedicines|September 23, 2022
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early SalvageDaniel Wegener, Daniel M Aebersold, Marc-Oliver Grimm, et al.Journal of Cellular Biochemistry|February 24, 2011
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonatesSylvia Thiele, Martina Rauner, Claudia Goettsch, et al.International Journal of Cancer|January 4, 2012
CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastasesDaniela Wuttig, Stefan Zastrow, Susanne Füssel, et al.The Canadian Journal of Urology|June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesUlf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.Nuklearmedizin. Nuclear Medicine|August 24, 2019
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patientsSebastian Hoberück, Enrico Michler, Gerd Wunderlich, et al.Pageof 25